Methods of treating obesity using a neurotensin receptor ligand

Details Methods of treating obesity using a neurotensin receptor ligand Methods of treating obesity using a neurotensin receptor ligand

A - Human Necessities

61

K

A61K 38/10 (2006.01) A61K 31/415 (2006.01) A61K 31/451 (2006.01) A61K 31/4709 (2006.01) A61K 31/505 (2006.01) A61K 38/08 (2006.01) A61K 38/22 (2006.01) A61K 45/06 (2006.01) A61P 3/04 (2006.01) A61P 3/10 (2006.01) A61P 9/10 (2006.01) A61P 15/12 (2006.01)

Patent

CA 2345180

The present invention relates to methods of treating obesity, diabetes, sexual dysfunction, atherosclerosis, insulin resistance, impaired glucose tolerance, hypercholesterolemia or hypertrigylceridemia using a neurotensin receptor ligand. The present invention also relates to pharmaceutical compositions and kits that comprise a neurotensin receptor ligand.

Affiliated with

Also associated with

Rating

Methods of treating obesity using a neurotensin receptor ligand does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of treating obesity using a neurotensin receptor ligand, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treating obesity using a neurotensin receptor ligand will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1807772